Robert Tonti, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3017 Fm 718, Newark, TX 76071 Phone: 817-956-3413 |
News Archive
Changes in markers of bone remodeling after one month of treatment with FORTEO® (teriparatide [rDNA origin] injection) may provide important early evidence of treatment response, according to new data presented today at the 86th Annual Meeting of The Endocrine Society (ENDO).
The first detailed results from AbbVie's pivotal phase III study, PEARL-III, were presented today as part of the 21st Conference on Retroviruses and Opportunistic Infections (CROI) press conference and will also be presented as a late-breaker at the conference on March 4.
According to a new study self-harm is becoming a major health issue among the elderly. This is bringing into focus the issue of mental health among the elderly. The results of the study titled, "Self-harm in older adults: systematic review," were published in the latest issue of the British Journal of Psychiatry.
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today additional preliminary results from an ongoing Phase 1 study of its lead development candidate, XMT-1001, in patients with advanced solid tumors.
Chris Collins, vice president and director of public policy at the Foundation for AIDS Research (amfAR), and Khai Hoan Tram, an Allan Rosenfield Fellow at amfAR, write in this Huffington Post opinion piece that what's missing from the discussion of foreign aid - which accounts for approximately one percent of the U.S. national budget - "is the fact that [it] is actually used to aid those in need while advancing our country's humanitarian and diplomatic goals.
› Verified 8 days ago